By 2027: Five Predictions for How CRISPR gene editing Will Transform Science & Discovery | Quantum Pulse Intelligence

For years, industry watchers have debated when CRISPR gene editing would reach an inflection point. According to new developments at NASA, that moment may have arrived. The developments around CRISPR gene editing have been building for some time. Industry observers who have tracked Science & Discovery closely say the signals were visible years ago — but the pace of change has accelerated dramatically in recent months. Industry benchmarks consistently show that CRISPR gene editing is outperforming alternative approaches in the Science & Discovery context. The margin of improvement has surprised even optimistic early adopters. The consensus among senior practitioners is that CRISPR gene editing represents more than an incremental advancement. It is, in the view of many, a categorical shift in how Science & Discovery operates at a fundamental level. **CRISPR gene editing in Context** The road ahead for CRISPR gene editing is not without obstacles. Regulatory frameworks have yet to fully catch up with the pace of development, and questions about standards and accountability remain open. The trajectory suggests CRISPR gene editing will remain a defining issue in Science & Discovery for the foreseeable future. Organizations that move decisively now are likely to build advantages that will be difficult for slower movers to overcome. In Science & Discovery, the conversation around CRISPR gene editing has moved well beyond theory. It is now, undeniably, about execution — and the organizations rising to that challenge are setting the terms for what follows.